AAAAAA

   
Results: 1-9 |
Results: 9
PHARMACOECONOMIC ANALYSIS OF TOPICAL TREATMENT FOR TINEA INFECTIONS
Authors: SHEAR NH EINARSON TR ARIKIAN SR DOYLE JJ VANASSCHE D
Citation: Nh. Shear et al., PHARMACOECONOMIC ANALYSIS OF TOPICAL TREATMENT FOR TINEA INFECTIONS, International journal of dermatology, 37(1), 1998, pp. 64-71
FULL-COST DETERMINATION OF DIFFERENT LEVELS OF CARE IN THE INTENSIVE-CARE UNIT - AN ACTIVITY-BASED COSTING APPROACH
Authors: DOYLE JJ CASCIANO JP ARIKIAN SR MAUSKOPF J PAUL JE
Citation: Jj. Doyle et al., FULL-COST DETERMINATION OF DIFFERENT LEVELS OF CARE IN THE INTENSIVE-CARE UNIT - AN ACTIVITY-BASED COSTING APPROACH, PharmacoEconomics, 10(4), 1996, pp. 395-408
PHARMACOECONOMIC ANALYSIS OF TOPICAL TREATMENTS FOR TINEA INFECTIONS
Authors: SHEAR NH EINARSON TR ARIKIAN SR DOYLE JJ
Citation: Nh. Shear et al., PHARMACOECONOMIC ANALYSIS OF TOPICAL TREATMENTS FOR TINEA INFECTIONS, PharmacoEconomics, 7(3), 1995, pp. 251-267
A MULTIFACTORIAL APPROACH TO UNDERSTANDING ANESTHESIA SELECTION
Authors: SUVER JD ARIKIAN SR SHANNON MC DOYLE JJ SWEENEY SW
Citation: Jd. Suver et al., A MULTIFACTORIAL APPROACH TO UNDERSTANDING ANESTHESIA SELECTION, Health care management review, 20(3), 1995, pp. 7-15
RANK-ORDER STABILITY ANALYSIS (ROSA) - TESTING PHARMACOECONOMIC DATA
Authors: EINARSON TR ARIKIAN SR DOYLE JJ
Citation: Tr. Einarson et al., RANK-ORDER STABILITY ANALYSIS (ROSA) - TESTING PHARMACOECONOMIC DATA, Medical decision making, 15(4), 1995, pp. 367-372
USE OF ANESTHESIA SELECTION IN CONTROLLING SURGERY COSTS IN AN HMO HOSPITAL
Authors: SUVER J ARIKIAN SR DOYLE JJ SWEENEY SW HAGAN M
Citation: J. Suver et al., USE OF ANESTHESIA SELECTION IN CONTROLLING SURGERY COSTS IN AN HMO HOSPITAL, Clinical therapeutics, 17(3), 1995, pp. 561-571
THE ANNUAL COST OF PSORIASIS
Authors: ARIKIAN SR EINARSON TR
Citation: Sr. Arikian et Tr. Einarson, THE ANNUAL COST OF PSORIASIS, Journal of the American Academy of Dermatology, 30(6), 1994, pp. 1047-1048
COST-EFFECTIVENESS ANALYSIS FOR ONYCHOMYCOSIS THERAPY IN CANADA FROM A GOVERNMENT PERSPECTIVE
Authors: EINARSON TR ARIKIAN SR SHEAR NH
Citation: Tr. Einarson et al., COST-EFFECTIVENESS ANALYSIS FOR ONYCHOMYCOSIS THERAPY IN CANADA FROM A GOVERNMENT PERSPECTIVE, British journal of dermatology, 130, 1994, pp. 32-34
A MULTINATIONAL PHARMACOECONOMIC ANALYSIS OF ORAL THERAPIES FOR ONYCHOMYCOSIS
Authors: ARIKIAN SR EINARSON TR KOBELTNGUYEN G SCHUBERT F ALLEN R BARAN R BERGMAN W BITETTO L BLATTSTEIN JS BREDA M CLEMENT W DECUYPER C DIFONZO E VANDOORSLAER E DOYLE JJ EFFENDY I EICHMANN A FEUILHADE M FIGUEIREDO A FLORI YA",GERMAINE,"CAMARASA JMG GINTER G GISBERT R GOODFIELD M GROENEWEG DA GUNN D HANNUKSELA M HAVU V KNAPPE E KOUSSIDOUEREMONTI T LATEUR N LEE RE LUCIONI C MATHIOUDAKI E MIKULITS R NOLTING S PANAGIOTIDOU D PEKURINEN M PEREIRA J REY JP PIETRINI P SOARES AP PIRARD C ROBERTS DT ROVIRA J RUFLI T RUTTEN F SOMMER JH SPANGLER E STARY A STAVRIANEAS N STAVROPOULOS P STUBB S TADDIO A TOPOLEWSKI K TOSTI A YFANTOPOULOS J VAGENA A VANHECKE E VARELTZIDIS A ZALINSKI J
Citation: Sr. Arikian et al., A MULTINATIONAL PHARMACOECONOMIC ANALYSIS OF ORAL THERAPIES FOR ONYCHOMYCOSIS, British journal of dermatology, 130, 1994, pp. 35-44
Risultati: 1-9 |